Porous metal-organic-framework nanoscale carriers as a potential platform for dr

ug delivery and imaging

P Horcajada, T Chalati, C Serre, B Gillet, C Sebrie - Nature materials, 2010 - na
ture.com
... significant anti-HIV activity was observed only for (AZT-TP)-charged nanopar
ticles (about 90%
inhibition ... of this last type of water molecule should induce an effect on th
e relaxation ... nanoMOFs
have many advantages when used as non-toxic and biocompatible drug nanocarriers
...
Cited by 702 Related articles All 10 versions Cite Save
[PDF] from aacrjournals.org
N-Nitroso compounds and childhood brain tumors: a case-control study
S Preston-Martin, CY Mimi, B Benton, BE Henderson - Cancer research, 1982 - AACR
... If she agreed, we scheduled a telephone interview at a time convenient for h
er. ... asked about 22
separate food items; we included traditional breakfast meats in a section on bre
akfast foods ... We
asked about face makeup in a section which included questions about the use of h
air ...
Cited by 309 Related articles All 4 versions Cite Save
[HTML] from nih.gov
The NCGC pharmaceutical collection: a comprehensive resource of clinically appro
ved drugs enabling repurposing and chemical genomics
R Huang, N Southall, Y Wang, A Yasgar - Science translational , 2011 - stm.science
mag.org
... These definitions clarify why there has been such confusion about what a Dru
g is and how many
there are and ... WHO) International Nonproprietary Names (INN) and United State
s Adopted Names
(USAN) registries, and compounds listed on the US tariff schedule (Table 2 ...
Cited by 112 Related articles All 12 versions Cite Save
[PDF] from iisc.ernet.in
[PDF] On the safety of nimesulide, a preferential COX-2 inhibitor
SK Kulkarni - CURRENT SCIENCE-BANGALORE-, 2002 - iisc.ernet.in
... The incidence of rare and unpredictable liver reactions with nimesulide is a
bout 0.1 per 100,000
treated ... Two years ago, a debate on the irrational combination of paraceta- m
ol with nimesulide
had also ... As per Rule 122B, D, E(C) (Appendix VI of Schedule Y) of the Drugs
and ...
Cited by 31 Related articles All 3 versions Cite Save More
[PDF] from indiaenvironmentportal.org.in
[PDF] The HPV vaccine: science, ethics and regulation
NB Sarojini, S Srinivasan, Y Madhavi - Econ Pol , 2010 - re.indiaenvironmentportal
.org.in
... So if these trials are not sanctioned by the scope of Schedule Y, then techn
ically they would be
illegal. The larger question raised by this survey of trials is one of r esearch
methodology: can
conclusions be made about a drug's long-term efficacy on the basis of short ...
Cited by 16 Related articles All 8 versions Cite Save More
[HTML] from jpgmonline.com
[HTML] Clinical information in drug package inserts in In

dia